STUDY OF HEPATIC DYSFUNCTION IN DENGUE PATIENT

SARTHAK BAJAJ; GURPREET SINGH MANDA; HARJAP SINGH

doi:10.22159/ijcpr.2025v17i6.8036

Authors

SARTHAK BAJAJ Department of Medicine, Mata Gujri Memorial Medical College and Lions Seva Kendra Hospital, Kishanganj, Bihar, India
GURPREET SINGH MANDA Government Medical College, Patiala, Punjab, India
HARJAP SINGH Government Medical College, Patiala, Punjab, India https://orcid.org/0009-0004-0191-1196

DOI:

https://doi.org/10.22159/ijcpr.2025v17i6.8036

Keywords:

Hepatic dysfunction, Dengue, Liver function, Liver involvement, Clinical study

Abstract

Objective: To evaluate the prevalence, severity, and clinical outcomes of hepatic dysfunction in dengue patients admitted to the Department of General Medicine at MGM Medical College and LSK Hospital, Kishanganj, Bihar.

Methods: A cross-sectional analysis was conducted on dengue-confirmed patients. Liver function parameters, including serum AST, ALT, bilirubin, and alkaline phosphatase levels, were assessed. Demographic and clinical data were analyzed to identify correlations between hepatic dysfunction and disease severity.

Results: Elevated AST and ALT levels were observed in 83.3% and 80% of patients, respectively, with severe elevations in 16.7% (AST) and 13.3% (ALT). Mild hyperbilirubinemia occurred in 26.7% and ALP elevation in 33.3% of cases. Jaundice was uncommon (6.7%), predominantly affecting younger adults (18–30 years), with males more frequently involved. Liver enzyme elevations correlated positively with disease severity, peaking in dengue shock syndrome (DSS) cases.

Conclusion: Hepatic dysfunction is a frequent and clinically significant complication of dengue fever. Liver enzyme elevations may serve as valuable markers of disease severity. Early recognition and monitoring of hepatic involvement are essential for improving patient outcomes. Further multicenter studies are needed to validate these findings and elucidate underlying mechanisms.

Downloads

Download data is not yet available.

References

1. Samanta J, Sharma V. Hepatic involvement in dengue fever. J Infect Dev Ctries. 2011;5(10):741-4.

2. Schilling S, Ludolfs D, Van An L, Schmitz H. Laboratory diagnosis of primary and secondary dengue infection. J Clin Virol. 2004;31(3):179-84. doi: 10.1016/j.jcv.2004.03.020, PMID 15465409.

3. Aggarwal R, Kapoor S, Lee JK. Hepatic dysfunction and dengue severity: a systematic review and meta-analysis. J Clin Epidemiol. 2016;69:105-17.

4. Gupta E, Dar L, Kapoor G, Broor S. The changing epidemiology of dengue in Delhi, India. Virol J. 2006;3:92. doi: 10.1186/1743-422X-3-92, PMID 17083743.

5. Shah GS, Islam S, Das BK. Clinical and laboratory profile of dengue infection in children. Kathmandu Univ Med J. 2006;4(1):40-3. PMID 18603866.

6. Karoli R, Fatima J, Siddiqi Z. Study of clinical profile of dengue fever in a North Indian Tertiary Care Hospital. J Assoc Physicians India. 2012;60:45-9.

7. Lee IK, Liu JW, Yang KD. Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. Am J Trop Med Hyg. 2005;72(2):221-6. doi: 10.4269/ajtmh.2005.72.221, PMID 15741560.

8. Malik AH, Jameel T, Haq E. The role of liver function tests in predicting outcome in dengue infection. Ann Hepatol. 2010;9(4):393-8.